TABLE 2.
Contraceptive method continuation of baseline Zika Contraception Access Network (Z-CAN) contraceptive method at 6, 24, and 36 months and method satisfaction among continuing users, Puerto Rico, 2016–2020
| All users |
Continuing users |
||||
|---|---|---|---|---|---|
| Baseline Z-CAN methoda | N b | Continuation (%) | Very satisfied (%) | Somewhat satisfied (%) | Not satisfied (%) |
| 6 months | |||||
| All methods | 82.5 | – | – | – | |
| Hormonal IUD | 726 | 92.0 | 70.2 | 27.0 | 2.8 |
| Copper IUD | 195 | 86.2 | 69.6 | 27.4 | 3.0 |
| Implant | 434 | 91.5 | 65.7 | 27.0 | 7.3 |
| Shot | 70 | 41.4 | 75.9 | 13.8 | 10.3 |
| Pills | 193 | 57.0 | 77.1 | 21.1 | 1.8 |
| Ring or patch | 69 | 46.4 | 93.8 | 6.3 | 0.0 |
| Condoms alone | 31 | 41.9 | –c | –c | –c |
| LARC | 1355 | 91.0 | 68.7 | 27.0 | 4.3 |
| Non-LARC d | 363 | 50.7 | 80.0 | 17.1 | 2.9 |
| 24 months | |||||
| All methods | 64.2 | – | – | – | |
| Hormonal IUD | 764 | 76.7 | 79.9 | 17.7 | 2.4 |
| Copper IUD | 216 | 70.4 | 74.5 | 23.5 | 2.0 |
| Implant | 454 | 66.3 | 63.9 | 28.1 | 8.0 |
| Shot | 56 | 10.7 | 100.0 | 0.0 | 0.0 |
| Pills | 198 | 37.9 | 79.7 | 16.2 | 4.1 |
| Ring or patch | 81 | 29.6 | 100.0 | 0.0 | 0.0 |
| Condoms alone | 33 | 36.4 | –c | –c | –c |
| LARC | 1434 | 72.5 | 74.4 | 21.6 | 4.0 |
| Non-LARC d | 368 | 31.8 | 85.6 | 11.5 | 2.9 |
| 36 months | |||||
| All methods | 49.9 | ||||
| Hormonal IUD | 733 | 69.9 | 82.8 | 13.9 | 3.3 |
| Copper IUD | 204 | 64.7 | 73.5 | 25.8 | 0.1 |
| Implant | 419 | 37.9 | 74.1 | 20.9 | 5.1 |
| Shot | 58 | 1.7 | 100.0 | 0.0 | 0.0 |
| Pills | 167 | 29.3 | 68.8 | 29.2 | 2.1 |
| Ring or patch | 74 | 23.0 | 93.8 | 6.3 | 0.0 |
| Condoms alone | 30 | 30.0 | –c | –c | –c |
| LARC | 1356 | 59.2 | 79.5 | 17.2 | 3.3 |
| Non-LARC d | 329 | 23.1 | 75.4 | 23.1 | 1.5 |
NOTE: Percentages calculated excluding missing data. Percentages may not sum to 100 due to rounding.
Abbreviations: IUD, intrauterine device; LARC, long-acting reversible contraception (includes IUDs and implants); Z-CAN, Zika Contraception Access Network.
Defined as the contraceptive method received at or within 30 days of the initial Z-CAN visit.
The Number of participants who responded to question assessing contraceptive method continuation.
No data on satisfaction of current users of condoms alone because of survey limitations (i.e., satisfaction was not ascertained).
Satisfaction among non-LARC continuing users excludes patients whose baseline method was condoms alone because of survey limitations (i.e., satisfaction was not ascertained).